Granulocyte growth factors in the treatment of non-small cell lung cancer (NSCLC)
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 58 (3) , 221-230
- https://doi.org/10.1016/j.critrevonc.2005.09.002
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- The importance of chemotherapy dose intensity in lung cancerSeminars in Oncology, 2004
- Multidisciplinary Management of Lung CancerNew England Journal of Medicine, 2004
- American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003Journal of Clinical Oncology, 2004
- Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors.Seminars in Oncology, 2003
- The case for the introduction of new chemotherapy agents in the treatment of advanced non small cell lung cancer in the wake of the findings of The National Institute of Clinical Excellence (NICE)British Journal of Cancer, 2002
- Dose and Dose Intensity as Determinants of Outcome in the Adjuvant Treatment of Breast CancerJNCI Journal of the National Cancer Institute, 1998
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis.Journal of Clinical Oncology, 1990